4//SEC Filing
Huang Dennis Karl 4
Accession 0001209191-22-015815
CIK 0001515673other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:09 PM ET
Size
9.6 KB
Accession
0001209191-22-015815
Insider Transaction Report
Form 4
Huang Dennis Karl
See Remarks
Transactions
- Award
Common Stock
2022-03-01+14,000→ 51,040 total - Award
Stock Option (Right to Buy)
2022-03-01+24,900→ 24,900 totalExercise: $67.37Exp: 2032-03-01→ Common Stock (24,900 underlying) - Sale
Common Stock
2022-03-01$66.62/sh−3,234$215,449→ 36,914 total
Footnotes (5)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
- [F2]Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
- [F3]Includes 126 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021.
- [F4]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F5]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001641217
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:09 PM ET
- Size
- 9.6 KB